BIOVERATIV INC. Revenue
BIOVERATIV INC. reported Revenue of $328.70 million for the 3-month period ending 2017-12-31, per its 10-K filed 2018-02-14.
Discontinued › Income Statement
us-gaap:Revenues · last filed 2018-02-14
- BIOVERATIV INC. revenues for the quarter ending 2017-12-31 was $328.70M, a 28.30% increase year-over-year.
- BIOVERATIV INC. revenues for the quarter ending 2017-09-30 was $291.60M, a 27.23% increase year-over-year.
- BIOVERATIV INC. revenues for the quarter ending 2017-06-30 was $289.10M, a 37.47% increase year-over-year.
- BIOVERATIV INC. revenues for the quarter ending 2017-03-31 was $259.10M, a 35.16% increase year-over-year.
- BIOVERATIV INC. revenues for fiscal 2017 was $1.17B, a 31.68% increase from fiscal 2016.
- BIOVERATIV INC. revenues for fiscal 2016 was $887.40M, a 58.38% increase from fiscal 2015.
- BIOVERATIV INC. revenues for fiscal 2015 was $560.30M.
| Period end | Revenues 3 month | Revenues 6 month | Revenues 9 month | Revenues 12 month |
|---|---|---|---|---|
| 2017-12-31 | $328.70M 10-K · filed 2018-02-14 | $620.30M derived: sum of 2 quarters · filed 2018-02-14 | $909.40M derived: sum of 3 quarters · filed 2018-02-14 | $1.17B 10-K · filed 2018-02-14 |
| 2017-09-30 | $291.60M 10-K · filed 2018-02-14 | $580.70M derived: sum of 2 quarters · filed 2018-02-14 | $839.80M 10-Q · filed 2017-10-27 | $1.10B derived: sum of 4 quarters · filed 2018-02-14 |
| 2017-06-30 | $289.10M 10-K · filed 2018-02-14 | $548.20M 10-Q · filed 2017-08-03 | $804.40M derived: sum of 3 quarters · filed 2018-02-14 | $1.03B derived: sum of 4 quarters · filed 2018-02-14 |
| 2017-03-31 | $259.10M 10-K · filed 2018-02-14 | $515.30M derived: sum of 2 quarters · filed 2018-02-14 | $744.50M derived: sum of 3 quarters · filed 2018-02-14 | $954.80M derived: sum of 4 quarters · filed 2018-02-14 |
| 2016-12-31 | $256.20M 10-K · filed 2018-02-14 | $485.40M derived: sum of 2 quarters · filed 2018-02-14 | $695.70M derived: sum of 3 quarters · filed 2018-02-14 | $887.40M 10-K · filed 2018-02-14 |
| 2016-09-30 | $229.20M 10-K · filed 2018-02-14 | $439.50M derived: sum of 2 quarters · filed 2018-02-14 | $631.20M 10-Q · filed 2017-10-27 | |
| 2016-06-30 | $210.30M 10-K · filed 2018-02-14 | $402.00M 10-Q · filed 2017-08-03 | ||
| 2016-03-31 | $191.70M 10-K · filed 2018-02-14 | |||
| 2015-12-31 | $560.30M 10-K · filed 2018-02-14 |